Financial Enhancement Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $332K | Buy |
1,309
+47
| +4% | +$11K | 0.04% | 116 |
|
|
2026
Q1 | $296K | Buy |
1,262
+236
| +23% | +$55K | 0.04% | 126 |
|
|
2025
Q4 | $224K | Sell |
1,026
-385
| -27% | -$76.1K | 0.03% | 134 |
|
|
2025
Q3 | $268K | Sell |
1,411
-19
| -1% | -$3.25K | 0.04% | 125 |
|
|
2025
Q2 | $224K | Sell |
1,430
-139
| -9% | -$21.4K | 0.03% | 123 |
|
|
2025
Q1 | $248K | Buy |
1,569
+15
| +1% | +$2.35K | 0.04% | 109 |
|
|
2024
Q4 | $225K | Sell |
1,554
-153
| -9% | -$23.7K | 0.03% | 113 |
|
|
2024
Q3 | $272K | Buy |
1,707
+142
| +9% | +$22.6K | 0.05% | 109 |
|
|
2024
Q2 | $252K | Buy |
1,565
+6
| +0.4% | +$892 | 0.04% | 106 |
|
|
2024
Q1 | $230K | Buy |
1,559
+38
| +2% | +$6.05K | 0.04% | 111 |
|
|
2023
Q4 | $244K | Sell |
1,521
-678
| -31% | -$104K | 0.04% | 106 |
|
|
2023
Q3 | $346K | Buy |
2,199
+150
| +7% | +$24.8K | 0.07% | 107 |
|
|
2023
Q2 | $348K | Buy |
2,049
+342
| +20% | +$55.2K | 0.06% | 110 |
|
|
2023
Q1 | $272K | Buy |
1,707
+52
| +3% | +$8.4K | 0.05% | 109 |
|
|
2022
Q4 | $271K | Sell |
1,655
-50
| -3% | -$8.63K | 0.05% | 108 |
|
|
2022
Q3 | $279K | Hold |
1,705
| – | – | 0.06% | 94 |
|
|
2022
Q2 | $303K | Hold |
1,705
| – | – | 0.07% | 91 |
|
|
2022
Q1 | $302K | Buy |
1,705
+51
| +3% | +$8.68K | 0.06% | 90 |
|
|
2021
Q4 | $283K | Sell |
1,654
-131
| -7% | -$21.4K | 0.05% | 94 |
|
|
2021
Q3 | $288K | Buy |
1,785
+1,138
| +176% | +$194K | 0.05% | 85 |
|
|
2021
Q2 | $107K | Sell |
647
-91
| -12% | -$15.1K | 0.02% | 108 |
|
|
2021
Q1 | $121K | Sell |
738
-85
| -10% | -$13.8K | 0.02% | 104 |
|
|
2020
Q4 | $130K | Buy |
823
+1
| +0.1% | +$148 | 0.03% | 107 |
|
|
2020
Q3 | $122K | Hold |
822
| – | – | 0.03% | 100 |
|
|
2020
Q2 | $116K | Hold |
822
| – | – | 0.03% | 106 |
|
|
2020
Q1 | $108K | Sell |
822
-120
| -13% | -$17K | 0.03% | 107 |
|
|
2019
Q4 | $137K | Sell |
942
-8
| -0.8% | -$1.08K | 0.03% | 90 |
|
|
2019
Q3 | $123K | Buy |
950
+184
| +24% | +$24.2K | 0.03% | 90 |
|
|
2019
Q2 | $107K | Sell |
766
-201
| -21% | -$27.8K | 0.03% | 103 |
|
|
2019
Q1 | $135K | Buy |
967
+441
| +84% | +$59.1K | 0.04% | 101 |
|
|
2018
Q4 | $73K | Hold |
526
| – | – | 0.02% | 113 |
|
|
2018
Q3 | $73K | Sell |
526
-88
| -14% | -$11.7K | 0.02% | 113 |
|
|
2018
Q2 | $75K | Sell |
614
-191
| -24% | -$23.8K | 0.03% | 106 |
|
|
2018
Q1 | $103K | Buy |
+805
| New | +$109K | 0.04% | 100 |
|
Other funds holding JNJ
Financial Enhancement Group's JNJ Position: Q2 2026 in Review
Financial Enhancement Group increased its Johnson & Johnson (JNJ) stake by 3.7% in Q2 2026, buying an estimated $11K and bringing the position to 1,309 shares worth $332K. The position accounts for 0.04% of the portfolio, ranked #116.
Financial Enhancement Group first reported a position in JNJ in Q1 2018 and has held it in 34 quarters since. The position peaked at $348K in Q2 2023. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Financial Enhancement Group held 1,309 shares of Johnson & Johnson worth $332K as of Q2 2026.
- Financial Enhancement Group bought 47 Johnson & Johnson shares in Q2 2026, an estimated $11K.
- Johnson & Johnson made up 0.04% of Financial Enhancement Group's portfolio in Q2 2026, its #116 holding.
- Financial Enhancement Group first reported a position in Johnson & Johnson in Q1 2018 and has held it in 34 quarters since.
- Financial Enhancement Group's Johnson & Johnson position peaked at $348K in Q2 2023.
- 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Financial Enhancement Group's 13F filing for Q2 2026, filed 7 Jul 2026.